Investor Relations

Company Overview

Aerami Therapeutics is developing differentiated inhaled therapies for the treatment of severe respiratory and other chronic diseases. Our platform is designed to overcome the limitations of injectable, oral, and other inhaled formulation technologies for managing severe respiratory and other chronic diseases. Ultimately, our aim is to improve treatment efficacy and improve patient lives.